At concentrations that produce anesthesia, many barbituric acid derivatives act as positive allosteric modulators of inhibitory GABA A receptors (GABA A Rs) and inhibitors of excitatory nicotinic acetylcholine receptors (nAChRs). Recent research on [ 3 H]R-mTFD-MPAB in the nAChR transmembrane domain: 1) a site within the ion channel, identified by photolabeling in the nAChR desensitized state of amino acids within the M2 helices of each nAChR subunit; and 2) a site at the g-a subunit interface, identified by photolabeling of gMet299 within the gM3 helix at similar efficiency in the resting and desensitized states. These results establish that mTFD-MPAB is a potent nAChR inhibitor that binds in the ion channel preferentially in the desensitized state and binds with lower affinity to a site at the g-a subunit interface where etomidate analogs bind that act as positive and negative nAChR modulators.
Introduction
Barbiturates encompass a large group of structurally related compounds that have been used clinically for their anxiolytic, anticonvulsant, sedative/hypnotic, and anesthetic effects (Mihic and Harris, 2011) . At clinically relevant concentrations, barbiturates interact with members of the pentameric ligand-gated ion channel superfamily, including inhibitory GABA A receptors (GABA A Rs) and excitatory nicotinic acetylcholine receptors (nAChRs) (Krasowski and Harrison, 1999; Rudolph and Antkowiak, 2004) . Barbiturates act as positive allosteric modulators of GABA A Rs (MacDonald and Olsen, 1994; Löscher and Rogawski, 2012) , the in vivo target for many of the anesthetic actions of pentobarbital (Zeller et al., 2007) . On the other hand, barbiturates act as noncompetitive/ allosteric inhibitors of muscle-type nAChRs, as shown using electrophysiological (Gage and McKinnon, 1985; Dilger et al., 1997; Krampfl et al., 2000) and ion flux assays (de Armendi et al., 1993) .
Barbiturates act as state-dependent inhibitors of the Torpedo (muscle-type) nAChR, with most having higher affinity for the open channel state than for the resting, closed channel state (de Armendi et al., 1993) . However, amobarbital, one of the most potent barbiturate inhibitors, binds with high affinity in the absence of agonist to one (Arias et al., 2001) or two (Dodson et al., 1987) sites per nAChR, with binding affinity reduced by .100-fold in the presence of agonist. Amobarbital and most barbiturates probably bind to a site in the nAChR ion channel, since they fully inhibit the binding of nAChR channel blockers (Cohen et al., 1986; Arias et al., 2001 ). However, there may be additional nAChR binding sites, since the N-methylated analog of barbital enhanced [
14 C]amobarbital binding, whereas barbital fully inhibited binding (Dodson et al., 1990) . In addition, in the presence of agonist, [ 14 C]amobarbital binds with low affinity to approximately 10 sites per nAChR (Arias et al., 2001) .
Cryoelectron microscopy analyses of the Torpedo [(a) 2 bgd] nAChR provided the first definition of the three-dimensional structure of a pentameric ligand-gated ion channel (Unwin, 2005) , with each subunit made up of an N-terminal extracellular domain, a transmembrane domain (TMD) made up of a loose bundle of four a helices (M1-M4), and a cytoplasmic domain composed of the amino acids between the M3 and M4 helices. The transmitter binding sites are in the extracellular domain at the a-g and a-d subunit interfaces. The M2 helices from each subunit associate around a central axis to form the ion channel, and the M1, M3, and M4 helices form an outer ring partly exposed to lipid.
Photoaffinity labeling studies have identified three classes of binding sites for allosteric modulators in the Torpedo nAChR TMD: 1) sites in the ion channel for "classical" cationic channel blockers, including chlorpromazine (Revah et al., 1990; Chiara et al., 2009 ) and tetracaine (Gallagher and Cohen, 1999) , as well as uncharged, hydrophobic drugs, including the general anesthetics etomidate and propofol (Pratt et al., 2000; Ziebell et al., 2004; Nirthanan et al., 2008; Hamouda et al., 2011; Jayakar et al., 2013) ; 2) a site at the g2a subunit interface that binds positive (Nirthanan et al., 2008) and negative modulators (Hamouda et al., 2011; Jayakar et al., 2013) ; and 3) a site for negative modulators, including halothane and propofol, within the d subunit helix bundle (Chiara et al., 2003; Arevalo et al., 2005; Hamouda et al., 2008; Jayakar et al., 2013) .
In this study, we used mTFD-MPAB [5-allyl-1-methyl-5-(m-trifluoromethyldiazirynylphenyl)barbituric acid; Fig. 1A) ], a recently developed photoreactive barbiturate general anesthetic that binds to intersubunit sites in the a1b3g2 GABA A R TMD (Savechenkov et al., 2012; Chiara et al., 2013) , to identify barbiturate binding site(s) in the Torpedo nAChR. Although R-mTFD-MPAB is 10-fold more potent than S-mTFD-MPAB as an anesthetic and GABA A R potentiator (Savechenkov et al., 2012) , we find that mTFD-MPAB is a potent inhibitor of Torpedo nAChR, with the S-isomer 2-fold more potent than the R-isomer. mTFD-MPAB binds with high affinity in the nAChR ion channel in the desensitized state, and direct photolabeling identified the amino acids contributing to the [ 3 H]R-mTFD-MPAB/pentobarbital binding sites in the ion channel and at the g2a subunit interface.
Materials and Methods
nAChR-rich membranes, isolated from Torpedo californica electric organs (Aquatic Research Consultants, San Pedro, CA) as described (Middleton and Cohen, 1991) [(5-allyl-1-methyl-5-phenyl) barbituric acid], R-and S-mTFD-MPAB, and [
3 H]R-mTFD-MPAB (38 Ci/mmol) were synthesized as described (Savechenkov et al., 2012 was determined using a centrifugation assay (Hamouda et al., 2011 H (cpm total 2 cpm nonspecific ) in the presence of competitor at concentration x, was normalized to f 0, the specifically bound 3 H in the absence of competitor. Data were fit using SigmaPlot 11 software (Systat Software, Inc., San Jose, CA) to the following single site model in eq. 1:
where IC 50 is the concentration of competitor that inhibits 50% of the total specific binding. Each drug concentration was tested at least three times on two oocytes. Representative current traces for R-mTFD-MPAB are plotted in the inset. The peak currents at each inhibitor concentration, normalized to the current elicited by 10 mM ACh alone, are plotted (average 6 S.E.). When fit to eq. 1, IC 50 values for R-and S-mTFD-MPAB are 10 6 2 and 5 6 1 mM, respectively.
Electrophysiological Recording. The effect of mTFD-MPAB on ACh-induced current responses for Torpedo nAChR expressed in Xenopus laevis oocytes was examined using standard two-electrode voltage clamp techniques as described (Hamouda et al., 2011) . Oocytes were obtained from adult female X. laevis using animal protocols approved by the Massachusetts General Hospital Subcommittee on Research Animal Care. Oocytes were injected with approximately 25 ng total mRNA mixed at a ratio of 2a:1b:1g:1d.
At room temperature and under continuous perfusion with ND96 (100 mM NaCl, 2 mM KCl, 10 mM Hepes, 1 mM EGTA, 1 mM CaCl 2 , 0.8 mM MgCl 2 , pH 7.5), oocytes were voltage clamped at 250 mV using an Oocyte Clamp OC-725C (Warner Instruments, Hamden, CT), and ACh (10 mM) 6 mTFD-MPAB was applied for 20-second intervals with an approximately 3-minute wash between applications. ACh-induced currents were digitized using a Digidata 1322A (Axon Instruments, Foster City, CA) and analyzed using Clampex/Clampfit 8.2 (Axon Instruments) and SigmaPlot 11 software. Peak currents were normalized to the peak current elicited by 10 mM ACh alone and were fit using eq. 1. R-and S-TFD-MPAB stocks were prepared in dimethylsulfoxide at a concentration of 100 mM and diluted in ND96 to the desired final concentrations. At the highest mTFD-MPAB concentrations tested, dimethylsulfoxide was at 0.1% (v/v), a concentration that altered ACh responses by ,5%.
[ ACh binding sites per condition) scales were performed using previously described photolabeling techniques (Nirthanan et al., 2008) . Briefly, nAChR-rich membranes (3 mM ACh sites, 2 mg protein/ml in TPS supplemented with 1 mM oxidized glutathione, an aqueous scavenger) were incubated with 1 mM [ 3 H]R-mTFD-MPAB for 40 minutes at 4°C in the absence or presence of other drugs and then irradiated on ice with a 365 nm UV lamp (model EN-280L; Spectronics Corporation, Westbury, NJ) for 30 minutes at a distance of ,2 cm. Photolabeled nAChR-rich membranes were resolved on 1.5-mm thick, 8% polyacrylamide/0.33% bis-acrylamide gels, and the polypeptides were visualized by staining with Coomassie Brilliant Blue R-250 (Amresco, Solon, OH; 0.25% w/v in 45% methanol and 10% acetic acid).
For analytical labeling, [ 3 H]R-mTFD-MPAB photoincorporation into individual polypeptides was visualized by fluorography and quantified by liquid scintillation counting of excised gel bands (Middleton and Cohen, 1991) . For photolabeling on a preparative scale, bands containing the nAChR subunits were excised from the stained, 8% polyacrylamide gels. The subunits were recovered by passive elution, concentrated to a final volume of 300 ml using centrifugal filtration (Vivaspin 15 Mr 5000 concentrators; Vivascience, Edgewood, NJ), acetone precipitated (75% acetone at 220°C, overnight), and resuspended in digestion buffer (15 mM Tris, 0.5 mM EDTA, 0.1% SDS, pH 8.1). Alternatively, gel bands for the nAChR a and g subunits were transferred to separate 15% polyacrylamide gels and subjected to in-gel digestion with 100 mg Staphylococcus aureus endoproteinase Glu-C (V8 protease) to generate large, nonoverlapping subunit fragments (aV8-20, aV8-18, aV8-10, gV8-24, gV8-14) (White and Cohen, 1988; Blanton and Cohen, 1994) , which were recovered from the mapping gel bands and resuspended in digestion buffer.
Enzymatic Digestions. All enzymatic digestions were performed at room temperature. The d subunit, the aV8-20 fragment (beginning at aSer173 and containing segment C of the agonist binding sites and the aM1, aM2, and aM3 helices), and the gV8-24 fragment (beginning at gAla167 and containing the gM1, gM2, and gM3 helices) were digested for 2 weeks with 0.5 unit Lysobacter enzymogenes endoproteinase Lys-C (EndoLys-C; Roche, Indianapolis, IN) or for 2 days with 1 mg EndoLys-C (6.3 unit/mg; Princeton Separations, Adelphia, NJ). The nAChR a and b subunits and the aV8-10 fragment (beginning at aAsn338 and containing the aM4 helix) were diluted with 0.5% Genapol (Calbiochem, La Jolla, CA) in 50 mM NH 4 HCO 3 buffer (pH 8.1) to reduce the SDS concentration to ,0.02%. Each sample was treated with 200 mg of L-1-tosylamido-2-phenylethylchloromethylketone-treated trypsin (Worthington Biomedical Corporation, Lake Township, NJ) in CaCl 2 (final concentration of 0.4 mM), and digestion was allowed to proceed for 8 hours (b subunit) or 2 days (a subunit and aV8-10). The nAChR b, g, and d subunits were digested for 2 days with 200 mg of V8 protease. The EndoLys-C digests of the d subunit and trypsin digests of the b subunit were resolved on small pore (16.5% T, 6% C) Tricine (Sigma-Aldrich) SDS-PAGE gels (Schägger and von Jagow, 1987; Arevalo et al., 2005) . The b and d subunit fragments recovered from the Tricine gels and the other subunit digests were further purified by reversed-phase high-performance liquid chromatography (rpHPLC).
HPLC Purification and Sequence Analyses. We performed rpHPLC and protein microsequencing as described (Nirthanan et al., 2008; Hamouda et al., 2011) . [ 3 H]R-mTFD-MPAB-labeled subunit fragments were purified on a Brownlee Aquapore BU-300 column (PerkinElmer), with material eluted at 0.2 ml/min using a nonlinear gradient increasing from 25% to 100% acetonitrile/isopropanol (3:2, 0.05% trifluoroacetic acid) over 100 minutes. The elution of peptides was monitored by the absorbance at 210 nm, and the elution of rpHPLC fractions were loaded onto trifluoroacetic acid-treated glass fiber or polyvinylidene difluoride filters that were then treated with Biobrene (Applied Biosystems, Foster City, CA) and sequenced on a PROCISE 492 protein sequencer (Applied Biosystems). For some samples, sequencing was interrupted at a specific cycle, and the filter was treated with o-phthalaldehyde (OPA). OPA reacts with primary amines, and this treatment prevents further sequencing of any peptide on the filter that does not contain proline (a secondary amine) at this cycle (Brauer et al., 1984; Middleton and Cohen, 1991) . For each cycle of Edman degradation, one-sixth was used for amino acid identification/ quantification and five-sixths were used for 3 H counting. The mass [f(x), in picomoles] of detected phenylthiohydantoin-amino acid derivative in cycle (x) was fit to the equation f(x) 5 I 0 R x to calculate the initial mass of the peptide sequenced (I 0 ) and the repetitive yield of Edman degradation (R), and then the photolabeling efficiency (in cpm/pmol) was calculated using the equation
Computational Analyses. A T. californica nAChR homology model was constructed based on the cryoelectron microscopy-derived structure of Torpedo marmorata nAChR [Protein Data Bank (PDB) ID 2BG9; Unwin, 2005] using the Discovery Studio (Accelrys, Inc., San Diego, CA) software package. The CDOCKER module (Wu et al., 2003) was used to dock R-mFTD-MPAB in binding site spheres (radius 5 20 Å) centered as follows: 1) in the nAChR ion channel at the level of M2-9/ 13, or 2) in the TMD at the g-a subunit interface and containing amino acids from aM1 (aPro211-aTyr234), aM2 (aThr244-aSer266), gM3 (gSer308-gLys285), and gM2 (gCys252-gLeu277). Twenty randomly distributed replicas of R-mFTD-MPAB were seeded in the center of the binding site spheres, and CDOCKER was configured to generate 20 ligand conformations from each seeded R-mFTD-MPAB replica and to refine the 20 lowest-energy docking solutions for each generated ligand conformation. Docking results within the ion channel and at the g-a subunit interface are shown as Connolly surface representations (1.4 Å diameter probe) of the ensemble of the 160 and 300 lowest-energy docking solutions, respectively.
A homology model of the T. californica nAChR TMD was constructed based on the structure of the Caenorhabditis elegans glutamate-gated chloride channel, GluCl (PDB ID 3RHW; Hibbs and Gouaux, 2011) , which differs from the cryoelectron microscopyderived nAChR structure in the vertical positioning of amino acids in the M2 and M3 helices relative to the M1 helices and may be a better representation of the locations of amino acids in the nAChR TMD (Mnatsakanyan and Jansen, 2013) . The T. californica nAChR and GluCl sequences were aligned through the M1 and M2 helices by use of the conserved Pro residues in M1 and at the end of M2 (M2-23).
Photoaffinity Labeling nAChR Barbiturate Binding Sites
Since no significant identity existed between the M3 helices of GluCl and the nAChR subunits, a secondary/tertiary structural alignment was made between GluCl and the neuronal b2 nAChR TMD NMR structure (PDB ID 2LM2; Bondarenko et al., 2012) using the Superimpose Proteins function of Discovery Studio, and the resulting sequence alignment was combined with a sequence alignment between Torpedo nAChR subunit TMD sequences and neuronal b2 nAChR TMD that share .50% identity. The final TMD alignment between GluCl and Torpedo nAChR subunits necessitated a oneresidue deletion in the aM1-M2 loop (after aPro236) and a one-residue insertion in the M2-M3 loop (aSer269/gLeu278). The resulting T. californica nAChR homology model was placed within a computergenerated membrane force field and energy minimized for 20 cycles, allowing for relaxation of any high-energy interactions induced by residue replacement.
Results mTFD-MPAB Inhibition of Torpedo nAChR. Since R-mTFD-MPAB is .10-fold more potent than S-mTFD-MPAB as an anesthetic and GABA A R potentiator (Savechenkov et al., 2012) , we examined the actions of both enantiomers on Torpedo nAChRs expressed in Xenopus oocytes. In the absence of agonist, neither enantiomer elicited a current response. When coapplied with ACh at 10 mM (EC 20 ), R-and S-mTFD-MPAB each produced reversible, concentration-dependent inhibition of ACh responses with IC 50 values of 10 6 2 mM and 5 6 1 mM, respectively (Fig. 1B) . Since the enantiomers were of similar potency as nAChR inhibitors and the resolved isomers were available only in limited supply, nonradioactive, racemic mTFD-MPAB was used in radioligand binding and photolabeling experiments.
To characterize mTFD-MPAB interactions with the transmitter binding sites, we compared its effects on the equilibrium binding of [ H]TCP, a PCP analog; Katz et al., 1997; Arias et al., 2003 Arias et al., , 2006 . Binding assays were performed in the presence of Carb, an agonist that stabilizes nAChRs in the desensitized state, or a-BgTx, a competitive antagonist that stabilizes the nAChR in the resting state. For Torpedo nAChRs in the desensitized state (1Carb), mTFD-MPAB inhibited [ 3 H]TCP binding with an IC 50 value of 2 6 0.2 mM (Fig. 2B) (Fig. 2B) . Similar to mTFD-MPAB, MPAB was more potent as an inhibitor in the desensitized state (IC 50 5 286 6 25 mM) than in the resting state (at 1 mM, ,20% inhibition of [ (Fig. 3A, lane 1) , and covalent incorporation of [ 3 H]R-mTFD-MPAB into individual polypeptides was evaluated by fluorography (Fig. 3A, lanes 2-5) and liquid scintillation counting of excised gel bands (Fig. 3B) . In the absence of other drugs (Fig. 3A, lane 2) , [ 3 H]R-mTFD-MPAB was photoincorporated most efficiently into the nAChR a and g subunits, and also into the b and d subunits and polypeptides from contaminating membranes [calelectrin (37K) and the Na 1 /K 1 -ATPase a subunit (a NaK )]. Photoincorporation into each nAChR subunit was enhanced in nAChRs photolabeled in the desensitized state (1Carb) compared with the resting state (no drug added), and that agonist-enhanced photolabeling was inhibitable by PCP and by pentobarbital. Tetracaine had no effect on nAChR subunit labeling when nAChRs were photolabeled in the absence of agonist (Fig. 3B) . To further characterize the pharmacological specificity of [ 3 H]R-mTFD-MPAB photoincorporation at the subunit level, we examined the concentration dependence of nonradioactive mTFD-MPAB or pentobarbital inhibition of subunit photolabeling when nAChRs were photolabeled in the desensitized state. Consistent with the concentration dependence of inhibition for [ 3 H]TCP binding, mTFD-MPAB and pentobarbital inhibited a subunit photolabeling with IC 50 values of 8 6 2 mM and 300 6 70 mM (Fig. 3C) .
Mapping [ 3 H]R-mTFD-MPAB Photoincorporation within nAChR a Subunit Fragments. In-gel digestion of photolabeled a subunits with V8 protease was used to localize [ 3 H]R-mTFD-MPAB photoincorporation within three large, nonoverlapping a subunit fragments: a 20-kDa fragment (aV8-20, containing agonist binding site segment C and the transmembrane M1-M3 helices), an 18-kDa fragment (aV8-18, containing most of the extracellular domain including agonist binding site segments A and B), and a 10-kDa fragment (aV8-10, containing part of the intracellular domain and the transmembrane M4 helix) (White and Cohen, 1988; Blanton and Cohen, 1994 ). In the absence or presence of Carb, [ 3 H]R-mTFD-MPAB photoincorporated in aV8-20 and aV8-10 with little, if any, labeling of aV8-18 (Fig. 4) . [ 3 H]R-mTFD-MPAB photoincorporation within aV8-20 was approximately 6-fold higher in the presence of Carb (desensitized state) than in its absence (resting state), and PCP inhibited that agonist-enhanced photolabeling. By contrast, photoincorporation within aV8-10 varied by ,20% in the absence or presence of agonist or PCP.
State-Dependent Photolabeling in the Ion Channel. The results of the binding assays and the pharmacological specificity of nAChR photolabeling at the level of intact subunits or aV8-20 predict that [ 3 H]R-mTFD-MPAB binds and photolabels amino acids in the nAChR ion channel in a state-dependent manner. To identify the amino acids photolabeled within the ion channel, nAChR-rich membranes were photolabeled, on a preparative scale, with 1 mM [ 3 H]R-mTFD-MPAB in the absence and presence of Carb, and subunit fragments beginning at the N termini of the bM2 and dM2 helices were isolated for amino acid sequence analysis. In the desensitized state (1Carb), [ 3 H]R-mTFD-MPAB photolabeled amino acids facing the channel lumen at positions extending from position M2-2, near the cytoplasmic end, to M2-17 (Fig. 5) . In the nAChR resting state, photolabeling of any of those residues, if it occurred, was at ,10% the efficiency of labeling in the desensitized state. Within bM2 (Fig. 5A), [ 3 H]mTFD-MPAB photolabeled bM2-9 (bLeu257) and bM2-13 (bVal261) most efficiently, with additional labeling at bM2-6 (bSer254) and bM2-17 (bLeu265). Within dM2, dM2-9 was labeled most efficiently, with dM2-2 (dSer258), dM2-6 (dSer262), and dM2-13 (dVal269) also photolabeled (Fig. 5B) .
Effects of PCP and Pentobarbital on [ 3 H]R-mTFD-MPAB Ion Channel Photolabeling. To further characterize [
3 H]R-mTFD-MPAB photolabeling within the ion channel in the desensitized state, nAChR-rich membranes were photolabeled with [ 3 H]R-mTFD-MPAB in the presence of Carb 6 100 mM PCP or 6 2 mM pentobarbital, and photoincorporation was determined in each of the M2 helices (Fig. 6 , A-D, abgd 6PCP; and A9-D9, abgd 6 pentobarbital). PCP inhibited photolabeling of dM2-2 and a/b/g/dM2-6 by .95% and photolabeling of M2-9 in each subunit by .80%. PCP enhanced photolabeling of bM2-13. Similarly, pentobarbital inhibited photolabeling of dM2-2 and a/b/g/dM2-6 by .85%. After duplicate samples were resolved on parallel SDS-PAGE gels and stained with Coomassie blue (A, lane 1), polypeptide bands were excised from one gel for 3 H determination while the second gel was prepared for fluorography before gel bands were excised for 3 H determination. (B) The average cpm 6 S.E. of both gels were plotted. The electrophoretic mobilities of the nAChR a, b, g, and d subunits, calectrin (37K), rapsyn (Rsn), and the Na + /K + -ATPase a subunit (a Na/K ) are indicated. (C) Inhibition of nAChR desensitized state photolabeling (a subunit) by nonradioactive mTFD-MPAB (d), pentobarbital (.), or 100 mM PCP (j). When data were fit to eq. 1 with PCP defining nonspecific subunit photolabeling, mTFD-MPAB and pentobarbital inhibited photolabeling with IC 50 values of 7.5 6 1.9 and 295 6 69 mM, respectively. Similar IC 50 values were also calculated for other nAChR subunits (not shown). PB, pentobarbital.
In contrast with PCP, photolabeling at position M2-9 was either reduced by approximately 15% (b, g) or enhanced by 100% (d) in the presence of pentobarbital, whereas photolabeling of bM2-13 and bM2-17 was reduced by approximately 70%.
Selective Photolabeling in M3 Helices of gMet299. When [ 3 H]R-mTFD-MPAB photoincorporation was analyzed at the level of intact subunits (Fig. 3) , there was greater photolabeling in the g subunit than in the b or d subunit in the absence of agonist, and that photolabeling was not inhibited by tetracaine, which suggested photolabeling outside the ion channel. Since photoreactive analogs of etomidate were known to bind to a site in the nAChR TMD at the g-a subunit interface and photolabel amino acids in gM3 (gMet295 and/ or gMet299; Nirthanan et al., 2008; Hamouda et al., 2011 ), we characterized [ 3 H]R-mTFD-MPAB photolabeling within the b, g, and d M3 helices (Fig. 7) . This was accomplished by sequencing fragments beginning at bThr273/gThr276/dThr281 that were generated by V8 protease cleavage and by chemical isolation of the fragments during sequencing by treatment of the sequencing filter with OPA before the sixth cycle of Edman degradation to block further sequencing of fragments not containing a proline at that cycle.
When the fragment beginning at gThr276 was sequenced (Fig. 7, A and B) , there was a single major peak of 3 H release in cycle 24, indicating photolabeling of gMet299 at similar efficiency in the resting and desensitized states (Fig. 7A , 58/65 cpm/pmol, respectively) with PCP having no effect on photolabeling in the desensitized state (Fig. 7B, 6 PCP 99/105 cpm/ mol). By contrast, no peaks of 3 H release were detected during sequencing through bM3 (Fig. 7C) or dM3 (Fig. 7D) , which indicated that any photolabeling would be at ,2 or ,4 cpm/ pmol.
Barbiturates Inhibit Photolabeling of gMet299. Amino acid sequence analyses of photolabeling in gM3 (Fig. 7) established state-independent [ 3 H]R-mTFD-MPAB photoincorporation at gMet299 and also established that there was little, if any, photolabeling of the residues in gM3 that are exposed to membrane lipid and photolabeled nonspecifically by [ (Fig. 4) that we localized to photolabeling of aCys412, the amino acid at the lipid-exposed face of aM4 helix that is most efficiently photolabeled by [ 125 I]TID (Blanton and Cohen, 1994 ) (see below). To evaluate the pharmacological specificity of gMet299 photolabeling compared with photolabeling of residues exposed at the lipid-protein interface, we examined the effects of nonradioactive mTFD-MPAB and pentobarbital on the efficiency of [ 3 H]R-mTFD-MPAB photolabeling at gMet299 and aCys412 in the absence of agonist. Whereas pentobarbital at 2 mM only partially (approximately 40%) reduced photolabeling at gMet299 (Fig. 8A) , mTFD-MPAB exhibited a nearly complete (.90% at 250 mM) and concentrationdependent inhibition of gMet299 photolabeling (IC 50 5 approximately 100 mM; Fig. 8, B and D) .
When the a subunit fragment beginning at aTyr401 that contains the aM4 helix was isolated from the same photolabeling experiments and sequenced, we found that photolabeling at aCys412 was partially inhibited by pentobarbital or mTFD-MPAB (Fig. 8C) . As shown in Fig. 8D , at each concentration of mTFD-MPAB, photolabeling of gMet299 was reduced more than the photolabeling of aCys412, with mTFD-MPAB at 250 mM reducing aCys412 photolabeling by only 55%, in contrast with the .90% reduction of gMet299 photolabeling. The decreasing ratio of gMet299/aCys412 Fig. 4. [ 3 H]R-mTFD-MPAB photoincorporation into nAChR a subunit fragments. Torpedo nAChR-rich membranes were photolabeled with 1 mM [ 3 H]R-mTFD-MPAB in the absence or presence of other ligands, and the polypeptides were resolved by SDS-PAGE. The stained bands containing nAChR a subunits were excised and transferred to a 15% acrylamide mapping gel and subjected to in-gel digestion with V8 protease to generate large subunit fragments that were visualized by GelCode Blue. The 3 H incorporation within the excised gel bands was determined by liquid scintillation counting. The locations of the subunit fragments within the a subunit primary structure are indicated above the graph. Data from two photolabeling experiments are shown in the absence (control) or presence of Carb and in the presence of Carb 6 PCP. Data for Carb conditions are the average 6 S.D. from the two experiments. photolabeling with increasing concentrations of mTFD-MPAB indicates that the inhibition at each site must result from different mechanisms and/or binding affinity.
Photolabeling in aM1. The selective [ 3 H]R-mTFD-MPAB photolabeling of gMet299 within the b/g/dM3 helices was similar to that seen for two photoreactive etomidate analogs (Nirthanan et al., 2008; Hamouda et al., 2011) . However, our sequencing results provided no evidence that [ 3 H]R-mTFD-MPAB photolabeled aM2-10 (Fig. 6A) , the other position at the g-a interface photolabeled by the photoetomidates. To extend the identification of nAChR amino acids contributing to the mTFD-MPAB binding site in proximity to gMet299, we characterized [
3 H]R-mTFD-MPAB photoincorporation within aM1, which also contributes amino acids to the g-a interface. The a subunit fragment beginning at aIle210 at the N terminus of aM1 was isolated for sequence analysis by rpHPLC from trypsin digests of a-subunits from nAChR photolabeled in the desensitized state (1Carb) in the absence and presence of pentobarbital (Fig. 9 ). The peak of 3 H release at cycle 22 of Edman degradation indicated photolabeling of aLeu231 at an efficiency that was approximately 30% of the level of photolabeling of aM2-6 or dM2-9 in the ion channel and approximately 5% of the level of photolabeling of gMet299 from the same experiment. Similar to gMet299, aIle231 was photolabeled at similar efficiency in the absence and presence of agonist (data not shown).
Photolabeling in the d Subunit Helix Bundle. We also wanted to determine whether [ Chiara et al., 2003; Hamouda et al., 2011; Jayakar et al., 2013) Arevalo et al., 2005; Garcia et al., 2007) that act as nAChR inhibitors photolabel in an agonist-dependent manner amino acids that contribute to this pocket from dM1 (dTyr228, dPhe232), dM2 (dM2-18), and/or the dM2-M3 loop (dIle288). Sequencing through dM2 (Fig. 6, D and D9 ) and the dM2-M3 loop (Fig. 7D ) 3 H (s, d, n, ,) and phenylthiohydantoin-amino acids (u, j) released during sequence analyses of fragments beginning at the N termini of aM2 (A and A9), bM2 (B and B9), gM2 (C and C9), and dM2 (D and D9) isolated from nAChRs photolabeled in the presence of Carb (d, j), Carb and 100 mM PCP (n, u; A-D), or Carb and 2 mM pentobarbital (,, ⬜; A9-D9). Fragments beginning at bMet242 and dMet257 were isolated as described in Fig. 5 . Fragments beginning at aMet243 and gCys252 were isolated by rpHPLC fractionation of EndoLys-C digests of aV8-20 and gV8-24, respectively, generated by subunit in-gel digestion with V8 protease. The initial yields (I 0 ) for the sequenced fragments (Carb/Carb + PCP, Carb/Carb + PB; in picomoles): aMet242 (A, 9/7; A9, 9/12), bMet249 (B, 9/8; B9, 2/3), gCys252 (C, 2/4; C9, 0.6/0.7) and dMet257 (D, 15/14; D9, 9/9) . For the bM2, gM2, and dM2 sequences, any other fragment, if present, was at , 10% of the mass of the M2 fragments. aM2 samples were contaminated by bM2 at ∼30% the level of aM2. The efficiencies of [ 3 H]R-mTFD-MPAB photolabeling (Carb/Carb + PCP, Carb/Carb + PB; in counts per minute per picomole) were as follows: for aM2: aM2-5 (17/0.3, 4.4/0.2) and aM2-6 (60/2, 17/3) (A and A9); for bM2: bM2-6 (5/0.2, 7/1), bM2-9 (22/4, 11/9), bM2-13 (3/9, 20/7), and bM2-17 (5/4, 6/1) (B and B9); for gM2: gM2-6 (43/0.7, 19/4) and gM2-9 (18/2, 13/6) (C and C9); and for dM2: dM2-2 (6/,1, 3/0.3), dM2-6 (9/0.4, 3/1), dM2-9 (30/3, 14/26), and dM2-13 (4/5, 5/3) (D and D9).
provided no evidence of [ 3 H]R-mTFD-MPAB photolabeling of amino acids contributing to the d subunit helix bundle, and we also found that any photolabeling of dPhe232 was at ,1% the level of photolabeling of dM2-9 in the ion channel (data not shown).
Discussion
In this work we used mTFD-MPAB, a photoreactive barbiturate general anesthetic (Savechenkov et al., 2012) , to provide new information about barbiturate interactions with the muscle-type Torpedo nAChR and to directly identify by photoaffinity labeling two barbiturate binding sites in the nAChR TMD. For nAChR expressed in Xenopus oocytes, mTFD-MPAB (IC 50 5 7 mM) was more potent than pentobarbital (IC 50 5 40 mM; Yost and Dodson, 1993) , the most potent Torpedo nAChR inhibitor identified in a screen of 14 barbiturates (de Armendi et al., 1993) . Based on the inhibition of radiolabeled, cationic nAChR channel blockers, mTFD-MPAB binds in the nAChR ion channel in the desensitized state (IC 50 5 2 mM) with approximately 70-fold higher affinity than in the resting, closed channel state. This state selectivity contrasts with that of amobarbital and pentobarbital, which have .100-fold and approximately 4-fold selectivity, respectively, for the channel in the resting state compared with the desensitized state (Cohen et al., 1986; Arias et al., 2001 ). However, mTFD-MPAB is N-methylated, and N-methylation of barbital and phenobarbital resulted in reduced affinity for the resting state and increased affinity for open channel and/ or desensitized states (de Armendi et al., 1993) .
[ Fig. 10 , A-D, in a model of the Torpedo nAChR structure based on cryoelectron microscopy (PDB ID 2BG9; Unwin, 2005) and in Fig. 10E in an homology model derived from the crystal structure of GluCl, an invertebrate glutamate-gated chloride channel (PDB ID 3RHW; Hibbs and Gouaux, 2011) . Computational docking studies predict that mTFD-MPAB can bind to each of these binding sites, and the predicted binding modes are shown in Fig. 10 , B-D, in Connolly surface representation.
Barbiturate Binding Site in the Ion Channel. For nAChRs in the desensitized state, the approximately 22 Å distance between the photolabeled amino acids at positions M2-2 and M2-17 exceeds the extended length of mTFD-MPAB (approximately 10 Å). However, the pharmacological specificity of photolabeling and computational docking studies indicate that [
3 H]R-mTFD-MPAB can bind in multiple orientations and at multiple levels in the ion channel. R-mTFD-MPAB (molecular volume 5 242 Å 3 ) docked within the Torpedo nAChR ion channel in two distinct orientations with similar energies. In the first cluster, the photoreactive diazirine was at the level of M2-13/17 with the long axis of mTFD-MPAB extending parallel to the M2 helices to below the level of M2-9. In the second cluster, mTFD-MPAB was rotated approximately 180°, with the diazirine at the level of M2-6/9 and the molecule extending to the level of M2-13. The ensemble of both clusters of mTFD-MPAB docked in the ion channel is shown in Fig. 10 , B and C, in a Connolly surface representation. H (s, d, ,) and phenylthiohydantoin-amino acids (u, j) released during sequence analyses of M3-containing fragments beginning at gThr276 (A and B), bThr273 (C), and dThr281 (D). The g and d subunits isolated from nAChRs photolabeled in the absence (s, u) or the presence of Carb (d, j) or Carb and 100 mM PCP (n, u) were digested with V8 protease, and the digests were fractionated by rpHPLC. For both digests, .95% of 3 H was eluted as a single hydrophobic rpHPLC peak that was pooled for sequencing, with OPA treatment at cycle 6 of Edman degradation (indicated by arrows). OPA treatment prevents further sequencing of peptides not containing a proline at cycle 6 and therefore chemically isolates fragments beginning at gThr276, bThr273, and dThr281 that each contain a proline at cycle 6. (A and B) After treatment with OPA, sequencing continued for the fragment beginning at gThr276 (A, 6Carb, approximately 2 pmol both conditions; B, +Carb/+Carb+PCP, 13/10 pmol) and for contaminating peptides beginning at bThr273 and dThr281 that were present at #25% the level of gThr276. The peak of 3 H release in cycle 24 indicates [ this homology model in the pocket at the g-a interface in proximity to the photolabeled amino acids (not shown). The vertical shift of nAChR amino acids in the M2 and M3 helices relative to the M1 helix in the nAChR 2BG9 structure compared with the GluCl structure occurs without any change of the M2 amino acids predicted to line the lumen of the ion channel. The differences may reflect actual differences in the nAChR and GluCl structures. However, our photolabeling results, in conjunction with recent cysteine crosslinking studies designed to determine the vertical alignment of amino acids in the nAChR M2 and M3 helices (Mnatsakanyan and Jansen, 2013) , provide experimental evidence favoring nAChR homology models based on the GluCl structure for the structure of the nAChR TMD.
R-mTFD-MPAB Interactions with nAChR and GABA A R. mTFD-MPAB has similar potency as a nAChR inhibitor (IC 50 5 5 mM) and GABA A R potentiator (EC 50 5 2 mM; Savechenkov et al., 2012) . However, the high-affinity binding sites are nonequivalent, as our results establish that R-or S-mTFD-MPAB binds in the nAChR ion channel (desensitized state), whereas the R-mTFD-MPAB binds with 20-fold higher affinity than the S-isomer to sites in the GABA A R TMD at the a 1 2b 2 and g 1 2b 2 subunit interfaces (Chiara et al., 2013) . The nAChR binding site at the g-a interface, identified by photoaffinity labeling of gMet299, however, is analogous to the R-mTFD-MPAB GABA A R intersubunit sites. In both receptors, these sites are located at subunit interfaces that do not contain transmitter binding sites in the extracellular domain, but the nAChR photolabeled amino acids site are located in the interface two helical turns lower (toward the cytoplasm) than those photolabeled in the GABA A R (Fig. 10F) .
Although mTFD-MPAB binds to nonequivalent, highaffinity sites in a nAChR and GABA A R, the TFD group is an important determinant of potency for both receptors. For nAChR in the desensitized state, mTFD-MPAB binds with 100-fold higher affinity in the ion channel than MPAB, whereas R-mTFD-MPAB binds with 20-fold higher affinity than R-MPAB to its GABA A R sites (Chiara et al., 2013) . This increase in affinity contributed by the TFD substituent is close to the calculated 80-fold increase in the partition coefficient predicted for that substituent, but the strong contribution of TFD to the energetics of mTFD-MPAB binding is not seen when that substituent is introduced into other general anesthetics. p-TFD-etomidate, a photoreactive analog of etomidate incorporating the TFD group on the phenyl ring of etomidate, binds to the GABA A R etomidate site with 10-fold lower affinity than etomidate (Chiara et al., 2013) and in the nAChR ion channel with 5-fold lower affinity (Hamouda et al., 2011) .
